Market capitalization | $14.09m |
Enterprise Value | $24.20m |
P/E (TTM) P/E ratio | negative |
P/B ratio (TTM) P/B ratio | 7.64 |
Cash position | $230.00k |
Short interest | 1.14% |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
1 Analyst has issued a forecast Upexi:
1 Analyst has issued a forecast Upexi:
Mar '25 |
+/-
%
|
||
Revenue | 3.16 3.16 |
78%
78%
|
|
Gross Profit | 1.34 1.34 |
2%
2%
|
|
EBITDA | -3.63 -3.63 |
6%
6%
|
EBIT (Operating Income) EBIT | -3.85 -3.85 |
22%
22%
|
Net Profit | -3.83 -3.83 |
7%
7%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. Its brands include LuckyTail, Prax, Cure Mushrooms, Moonwlkr, and Gumi Labs. The company was founded on September 5, 2018 and is headquartered in Tampa, FL.
Head office | United States |
CEO | Allan Marshall |
Employees | 64 |
Website | www.upexi.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.